Mather Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $184K | Sell |
2,354
-170
| -7% | -$13.7K | ﹤0.01% | 789 |
|
|
2026
Q1 | $219K | Sell |
2,524
-464
| -16% | -$44.5K | ﹤0.01% | 712 |
|
|
2025
Q4 | $287K | Buy |
2,988
+372
| +14% | +$36.1K | ﹤0.01% | 534 |
|
|
2025
Q3 | $249K | Hold |
2,616
| – | – | ﹤0.01% | 569 |
|
|
2025
Q2 | $228K | Buy |
2,616
+46
| +2% | +$3.9K | ﹤0.01% | 571 |
|
|
2025
Q1 | $231K | Buy |
2,570
+53
| +2% | +$4.74K | ﹤0.01% | 550 |
|
|
2024
Q4 | $201K | Buy |
2,517
+167
| +7% | +$14.5K | ﹤0.01% | 560 |
|
|
2024
Q3 | $212K | Sell |
2,350
-954
| -29% | -$80.3K | ﹤0.01% | 552 |
|
|
2024
Q2 | $288K | Buy |
3,304
+197
| +6% | +$16.1K | ﹤0.01% | 544 |
|
|
2024
Q1 | $256K | Buy |
3,107
+14
| +0.5% | +$1.2K | ﹤0.01% | 472 |
|
|
2023
Q4 | $255K | Sell |
3,093
-3,895
| -56% | -$297K | ﹤0.01% | 489 |
|
|
2023
Q3 | $548K | Buy |
6,988
+1,295
| +23% | +$108K | 0.01% | 310 |
|
|
2023
Q2 | $502K | Buy |
5,693
+2,040
| +56% | +$176K | 0.01% | 347 |
|
|
2023
Q1 | $294K | Sell |
3,653
-7,102
| -66% | -$579K | 0.01% | 398 |
|
|
2022
Q4 | $836K | Sell |
10,755
-1,358
| -11% | -$110K | 0.02% | 233 |
|
|
2022
Q3 | $978K | Sell |
12,113
-1,218
| -9% | -$109K | 0.02% | 199 |
|
|
2022
Q2 | $1.2M | Sell |
13,331
-4
| -0% | -$405 | 0.03% | 163 |
|
|
2022
Q1 | $1.48M | Buy |
13,335
+255
| +2% | +$26.9K | 0.03% | 132 |
|
|
2021
Q4 | $1.35M | Buy |
13,080
+4,111
| +46% | +$476K | 0.03% | 126 |
|
|
2021
Q3 | $1.12M | Sell |
8,969
-812
| -8% | -$105K | 0.03% | 108 |
|
|
2021
Q2 | $1.21M | Buy |
9,781
+205
| +2% | +$25.7K | 0.03% | 96 |
|
|
2021
Q1 | $1.13M | Sell |
9,576
-1,387
| -13% | -$163K | 0.03% | 92 |
|
|
2020
Q4 | $1.28M | Buy |
10,963
+695
| +7% | +$76.5K | 0.04% | 81 |
|
|
2020
Q3 | $1.07M | Sell |
10,268
-759
| -7% | -$76.2K | 0.04% | 87 |
|
|
2020
Q2 | $1.01M | Buy |
11,027
+6,647
| +152% | +$637K | 0.05% | 86 |
|
|
2020
Q1 | $395K | Sell |
4,380
-200
| -4% | -$21.3K | 0.03% | 99 |
|
|
2019
Q4 | $520K | Buy |
+4,580
| New | +$503K | 0.03% | 85 |
|
|
2019
Q1 | – | Sell |
-28,051
| Closed | -$2.55M | – | 76 |
|
|
2018
Q4 | $2.55M | Buy |
28,051
+4,838
| +21% | +$452K | 0.23% | 34 |
|
|
2018
Q3 | $2.28M | Buy |
23,213
+8,791
| +61% | +$813K | 0.2% | 23 |
|
|
2018
Q2 | $1.24M | Buy |
14,422
+11,703
| +430% | +$978K | 0.12% | 31 |
|
|
2018
Q1 | $218K | Buy |
+2,719
| New | +$224K | 0.02% | 45 |
|
Other funds holding MDT
Mather Group's MDT Position: Q2 2026 in Review
Mather Group reduced its Medtronic (MDT) stake by 6.7% in Q2 2026, selling an estimated $13.7K and leaving 2,354 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #789.
Mather Group first reported a position in MDT in Q1 2018 and has held it in 31 quarters since. The position peaked at $2.55M in Q4 2018. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Mather Group held 2,354 shares of Medtronic worth $184K as of Q2 2026.
- Mather Group sold 170 Medtronic shares in Q2 2026, an estimated $13.7K.
- Medtronic made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #789 holding.
- Mather Group first reported a position in Medtronic in Q1 2018 and has held it in 31 quarters since.
- Mather Group's Medtronic position peaked at $2.55M in Q4 2018.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.